Substituted phenylphosphates as mutual prodrugs of steroids and beta - agonists for the treatment of pulmonary inflammation and bronchoconstriction

Details for Australian Patent Application No. 2006259604 (hide)

Owner Corus Pharma, Inc.

Inventors Stasiak, Marcin; Baker, William R.; Girton, Bruce Charles

Agent Spruson & Ferguson

Pub. Number AU-A-2006259604

PCT Pub. Number WO2006/138212

Priority 60/690,545 14.06.05 US

Filing date 12 June 2006

Wipo publication date 28 December 2006

International Classifications

A61K 31/58 (2006.01) - containing heterocyclic rings, e.g. aldosterone, danazol, stanozolol, pancuronium, digitogenin

C07J 71/00 (2006.01) Steroids in which the cyclopenta[a]hydrophenanthrene skeleton is condensed with a heterocyclic ring

Event Publications

10 January 2008 PCT application entered the National Phase

  PCT publication WO2006/138212 Priority application(s): WO2006/138212

31 January 2008 Assignment before Grant

  Corus Pharma, Inc. The application has been assigned to Gilead Sciences, Inc. 2007

20 May 2010 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(a). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006259605-Ophthalmic and otorhinolaryngological device materials

2006259598-Pilot and data transmission in a MIMO system applying subband multiplexing